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Conclusions: Individuals with contact with foreign countries had high
rates of intestinal colonization by Enterobacteriaceae producing CTX-
M-types, especially those of the CTX-M-1 cluster. Our study points out
the importance of ecological surveillance studies of faecal carriers of
multi-drug resistance organisms to establish epidemiological measures
that would allow controlling the dissemination of these organisms.
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Objectives: Carbapenem resistance in Enterobacteriaceae is one of the
actual major therapeutic concerns. Routine procedures of the hospital
clinical microbiology laboratory, alerted for the need of extensive study
of some Enterobacteriaceae isolates in order to better understand the
resistance profile, namely in isolates that showed reduced susceptibility
or resistance to, at least, one type of carbapenem. With that purpose,
isolates were selected for genotypic approach by PCR and sequencing.
Methods: In a set of 13 Enterobacteriaceae showing reduced
susceptibility to carbapenems, collected since September 2010 till
September 2011, a Klebsiella pneumoniae blood culture isolate,
showed resistance to oxiimino-beta-lactams, resistance to meropenem,
reduced susceptibility to ertapenem, and susceptibility to imipenem,
with MICs of 16, 4 and 2 lg/mL respectively, and susceptibility to
aminoglycosides and fluoroquinolones. Identification and susceptibility
testing were performed by Vitek2 (bioMe´rieux) and WalkAway
(Dadebehring) systems. Total DNA of this Klebsiella pneumoniae,
was subjected to amplification by multiplex PCR using primers for
blaVIM, blaIMP and blaKPC and sequencing of the amplified fragment,
using ABI-PRISM 3100 automatic genetic analyzer, showing the
presence of blaIMP-22.
Results: In this study, we detected blaIMP-22, in a clinical isolate of
Klebsiella pneumoniae. According to the CLSI guidelines, extended-
spectrum b-lactamases production was not detected. Metalo-b-
lactamases detection, by Etest MIC determination for imipenem and
imipenem plus EDTA, was negative, highlighting the need of adequate
phenotypic detection of this particular resistance threats. Genotypic
determination of this resistance mechanism, seems useful in these
situations of Imipenem susceptibility, masking carbapenemase
production. This is an important issue to interpret hospital resistance
epidemiology and to guide infection control procedures, to avoid
outbreak installation.
Conclusions: As far as it seems, this is the first report of blaIMP-22 in
a Klebsiella pneumoniae clinical isolate. The acquired metallo-b-
lactamases represent a significant clinical threat due to their hydrolysis
spectrum and infection control challenge. These atypical
carbapenemase-producers may be overlooked in routine clinical
microbiology laboratory testing, emphasizing the importance to
survey and control the spread of such resistance determinants in
nosocomial pathogens.
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Objectives: To characterise the antimicrobial resistance determinants
present in Moraxella osloensis, isolated from human clinical trial
studies.
Methods: Four M. osloensis isolates from the skin of two participants,
one a placebo and one part of a clinical trial study undergoing
antimicrobial treatment of Minocycline (EU ANTIRESDEV Project)
were characterized using an antimicrobial resistance (AMR) gene
microarray chip (Clondiag TM GmbH). Phenotypic characterisations
were determined by antimicrobial disk diffusion assays and Phenotype
Micro (PM) arrays from Biolog.
Results: Three of the four M. osloensis isolates from the skin trunk of
human volunteers showed multiple resistance, both geno- and pheno-
typically to sulphonamide, beta- lactamase and tetracycline and
produced positive signals for antibiotic resistance genes sul2, sul3,
blaCMY, blaPER, blaOXA2 and tet37 with the microarray. The fourth
strain was sensitive to all antibiotics tested and did not produce any
positive signals with the AMR gene array. Biochemical characteristics
determined using the PM arrays showed differences between the AMR
resistance and sensitive strains.
Conclusion: Moraxella osloensis is an opportunistic human pathogen
known to cause diseases such as endocarditis, osteomyelitits, septic
arthritis, catheter infection and meningitis. At present all diseases have
been treatable and currently there is no record in the literature of M.
osloensis with multiple antibiotic resistances. The present discovery of
multiple drug resistance in isolates of human origin is worrying and
follows a growing trend of multiple resistances acquired in bacterial
pathogens.
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The purpose of this study was to establish the main resistance
phenotypes and their genetic determinants in Gram-negative bacilli
(GNB) isolated from intensive care units (ICU).
Material and Methods: A number of 531 GNB strains (334
Enterobacteriaceae and 197 Pseudomonadaceae) were isolated from
1166 positive clinical samples collected from patients hospitalized
during 2011, in the ICUs of two big hospital from Buhcarest, Romania.
Their resistance phenotypes were established using: disk diffusion test,
double-disk diffusion test (DDST) with amoxicillin-clavulanic acid
(AMC), cefotaxime (CTX) and ceftazidime (CAZ), DDST with AMC
plus EDTA, imipenem (IPM) and IMP plus EDTA, Modified Hodge
Test (MHT) and E-test ESBL, MBL and AmpC. The genetic support of
the antibiotic resistance was investigated by simple and multiplex PCR
reactions for class A Ser- b-lactamases (PSE, CARB, TEM genes
families), class B – metallo-b-lactamases -MBL (IMP, VIM, SPM gene
families), class C – AmpC and ESBL, as well as ciprofloxacin resistance
genes (gyrA, parC) as well as the presence of mexB, mexD, mexF and
mexY genes, encoding for multi-drug efflux pumps. In accordance with
the recommended definitions of the degree of multidrug resistance, 32%
of the GNB exhibited a multi-drug resistance (MDR) phenotype
(Escherichia sp., Klebsiella sp., Serratia sp., Acinetobacter sp.,
Pseudomonas sp.), 13.2% were extended-drug resistant (XDR)
(Klebsiella sp., Acinetobacter sp.) and 5.6% pan-drug resistant (PDR)
(Enterobacter sp. and Klebsiella sp.). The gyrA gene, as well as the
mexB, mexD, mexF si mexY genes, encoding for the efflux pumps
mexAB-oprM, mexEF-oprN10 si mexCD-oprJ were detected in
ciprofloxacin resistant strains and also correlated with the phenotypic
resistance to aminoglycosides and carbapenems. The ESBL phenotype
was correlated with the presence of blaSHV, blaTEM and blaPSE
genes, while the MBL phenotype with the presence of blaVIM gene.
Conclusion: The increasing resistance in GNR provides an important
signal that we need to improve our understanding of the genetic and
biochemical basis of resistance mechanisms in the bacterial strains
circulating in our geographical area, by using phenotypic and resistance
genotyping tools.
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